Sepsis is a life threatening condition where the body overreacts to an infection. B•R•A•H•M•S PCT is the best biomarker for early bacterial infection diagnosis and antibiotic stewardship.
Choose your VITROS® model to check your assays:
D = In development/currently not available
* MicroTip Partnership Assay (MPA); Reagents and validated applications available directly from Ortho Clinical Diagnostics; Product availability subject to third party’s or their agent’s capability to support the laboratories.
Supplier information:
1. DiAgam
2. Thermo Fisher Scientific Inc
3. Diazyme Laboratories, Inc
CA 125 II™, CA 15-3™ and CA 19-9™ are trademarks of Fujirebio Diagnostics Inc.
CEDIA®, DRI® and QMS® are registered trademarks of Thermo Fisher Scientific and its subsidiaries.
HIV and Hepatitis co-developed with Grifols.
**Product availability is subject to fulfillment of regulatory requirements in each market.
It’s never too early to know. Your patients trust you to deliver reliable results. So, what are your testing protocols doing to inspire that confidence? Our HIV Combo test provides early detection of acute HIV-1 infection with class-leading 4th-generation antigen sensitivity combined with uncompromised specificity.
Together we can find a solution
